However, this is at odds with the results of the study involving stable coronary heart disease patients who were naïve to lipid-lowering therapy [22], they reported a positive correlation between PCSK9 and WBC, which might be due to the difference existing in the study population. This evidence concerns the gene PCSK9 and coronary artery disorder.